Robert Chen and his team like strategies like direct indexing because they systematically tax loss harvest throughout the ...
"Everybody knows you made a mistake. How are you going to deal with that?" ...
While Citi, BofA and Goldman touted their biggest cohorts of managing directors in years, Morgan Stanley elevated greater ...
Vir Biotechnology's Phase 1 data highlights early promise for T-cell engagers targeting HER2-positive tumors and prostate ...
The popularity of alcohol-free Guinness won’t protect the shares of its owner Diageo Plc from the growing trend toward health ...
Jim Caron of Morgan Stanley Investment Management explains what's behind the steepening yield curve and what it's telling us ...
JP Morgan analyst Kian Abouhossein maintained a Neutral rating and boosted the price target from $100 to $104 on Dec. 6, 2024 ...
Among 26 home price forecast models tracked by ResiClub, Morgan Stanley is the most bearish on the 2025 housing market.
Morgan Stanley has upgraded Gilead Sciences (NASDAQ:GILD) to overweight from equal weight, citing the company's HIV drug ...